Orange Book product · Generic (ANDA)
CHLORPROMAZINE HYDROCHLORIDE
CHLORPROMAZINE HYDROCHLORIDE
At a glance
Dec 10, 2024
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 10, 2024
1 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
CHLORPROMAZINE HYDROCHLORIDE
Strength
25MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 216724
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CHLORPROMAZINE HYDROCHLORIDE
- —THORAZINEBrand (NDA)
NDA 011120 · GLAXOSMITHKLINE
- —THORAZINEBrand (NDA)
NDA 009149 · GLAXOSMITHKLINE
- 2026CHLORPROMAZINE HYDROCHLORIDEGeneric (ANDA)
ANDA 216092 · MSN
- 2025CHLORPROMAZINE HYDROCHLORIDEGeneric (ANDA)
ANDA 216678 · RUBICON RESEARCH
- 2025CHLORPROMAZINE HYDROCHLORIDEGeneric (ANDA)
ANDA 216788 · AUROBINDO PHARMA LTD
- 2024CHLORPROMAZINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218272 · ASPIRO
- 2024CHLORPROMAZINE HYDROCHLORIDEGeneric (ANDA)
ANDA 216911 · GLAND
- 2024CHLORPROMAZINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218229 · DEVA HLDING
- 2024CHLORPROMAZINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217275 · ZYDUS PHARMS
- 2023CHLORPROMAZINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217350 · ALEMBIC
- 2021CHLORPROMAZINE HYDROCHLORIDEGeneric (ANDA)
ANDA 214542 · GENUS
- 2021CHLORPROMAZINE HYDROCHLORIDEGeneric (ANDA)
ANDA 212144 · GLENMARK PHARMS LTD
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
